Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Steven Shak0
Susan D. Hellmann0
Virginia E. Paton0
Date of Patent
February 22, 2011
Patent Application Number
10356824
Date Filed
February 3, 2003
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with a combination of an anti-ErbB2 antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
